Target ALS 2023 Annual Report
January 6, 2024 Tammy Sutherns

Over the past decade, Target ALS has ushered in a transformative era in ALS research, championing collaboration and driving innovation to make significant strides toward effective treatments for those living with ALS. While we take pride in the progress we’ve made, we are more determined than ever to elevate our efforts as we step into the next phase of our journey.
Related News
Science on Target: Q3 Publications from our Innovation Ecosystem
October 7, 2026
Science on Target: Q3 Research We Enable
October 7, 2026
Science on Target: Q3 Research We Conduct
October 7, 2026
Science on Target: Q3 Research We Fund
October 7, 2026